Max M Wolf Selected Research

denileukin diftitox (Ontak)

5/2004

Confirmation of the activity of the interleukin-2 fusion toxin denileukin diftitox against chemorefractory chronic lymphocytic leukemia, including cases with chromosome 17p deletions and without detectable CD25 expression.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Max M Wolf Research Topics

Disease

2	Central Nervous System Diseases (CNS Diseases) 12/2012 - 10/2009
2	Multiple Myeloma 12/2012 - 06/2005
2	Waldenstrom Macroglobulinemia (Macroglobulinemia) 12/2010 - 09/2005
2	Infections 08/2006 - 11/2004
2	Neoplasms (Cancer) 11/2004 - 05/2004
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 08/2006
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 04/2005
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 05/2004

Drug/Important Bio-Agent (IBA)

6	fludarabineIBA 12/2010 - 05/2004
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 04/2005 - 05/2004
2	Rituximab (Mabthera)FDA Link 12/2010 - 04/2005
1	Bortezomib (Velcade)FDA Link 12/2012
1	Lenalidomide (CC 5013)FDA Link 12/2012
1	Thalidomide (Thalomid)FDA Link 12/2012
1	P-2 (P 2)IBA 08/2006
1	purineIBA 09/2005
1	Alkylating AgentsIBA 09/2005
1	liposomal doxorubicin (Doxil)FDA Link 06/2005
1	Dexamethasone (Maxidex)FDA LinkGeneric 06/2005
1	Vincristine (Oncovin)FDA LinkGeneric 06/2005
1	Mitoxantrone (Novantrone)FDA LinkGeneric 11/2004
1	Interleukin-2 (IL2)IBA 05/2004
1	denileukin diftitox (Ontak)FDA Link 05/2004

Therapy/Procedure

3	Drug Therapy (Chemotherapy) 12/2012 - 10/2009
3	Therapeutics 12/2012 - 11/2004
2	Salvage Therapy 12/2010 - 09/2005
2	Combination Drug Therapy (Combination Chemotherapy) 08/2006 - 11/2004
1	Stem Cell Transplantation 12/2012